Study of Oregon's legal mushroom experiment shows promise : NPR

Key Points:

• A new study analyzing nearly 350 participants in Oregon's regulated psilocybin program found that most users reported beneficial and meaningful experiences, with the program showing an overall favorable safety profile.
• Only a very small number of participants experienced serious adverse reactions, mostly first-time users, and the rate of negative events was comparable to other psychiatric interventions.
• The study reflects Oregon's unique nonmedical psilocybin model, allowing adults over 21 to use the drug under supervision without a prescription, differing from clinical trials focused on medical approval.
• Researchers caution that the study sample was limited and skewed toward white, college-educated, higher-income individuals, which may affect the generalizability of the findings.
• Despite some concerns about adverse effects and mental health risks, researchers plan to expand the study with a larger sample and remain optimistic about the prospects of a regulated psychedelic industry.